Sędziak-Marcinek, B.; Wylęgała, A.; Chełmecka, E.; Wylęgała, E.; Teper, S.
How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients. J. Clin. Med. 2021, 10, 3572.
https://doi.org/10.3390/jcm10163572
AMA Style
Sędziak-Marcinek B, Wylęgała A, Chełmecka E, Wylęgała E, Teper S.
How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients. Journal of Clinical Medicine. 2021; 10(16):3572.
https://doi.org/10.3390/jcm10163572
Chicago/Turabian Style
Sędziak-Marcinek, Bogumiła, Adam Wylęgała, Elżbieta Chełmecka, Edward Wylęgała, and Sławomir Teper.
2021. "How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients" Journal of Clinical Medicine 10, no. 16: 3572.
https://doi.org/10.3390/jcm10163572
APA Style
Sędziak-Marcinek, B., Wylęgała, A., Chełmecka, E., Wylęgała, E., & Teper, S.
(2021). How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients. Journal of Clinical Medicine, 10(16), 3572.
https://doi.org/10.3390/jcm10163572